Cost of Treatment for Relapsed/Refractory Multiple Myeloma.

Am Health Drug Benefits

Celgene Corporation, Summit, NJ.

Published: December 2015

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719135PMC

Publication Analysis

Top Keywords

cost treatment
4
treatment relapsed/refractory
4
relapsed/refractory multiple
4
multiple myeloma
4
cost
1
relapsed/refractory
1
multiple
1
myeloma
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!